We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+13.66%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$59.3B
AUM Growth
+$5.36B
Cap. Flow
+$49.9M
Cap. Flow %
0.08%
Top 10 Hldgs %
30.78%
Holding
972
New
135
Increased
326
Reduced
323
Closed
129

Top Buys

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$111M
2
AMZN icon
Amazon
AMZN
+$108M
3
COF icon
Capital One
COF
+$106M
4
JCI icon
Johnson Controls International
JCI
+$99.8M
5
NEE icon
NextEra Energy
NEE
+$98M

Sector Composition

Rank Sector Weight
1 Technology 29.16%
2 Healthcare 13.82%
3 Financials 12.25%
4 Consumer Discretionary 9.51%
5 Industrials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CABA icon
551
Cabaletta Bio
CABA
$439M
$13.4M 0.02%
8,829,758
+5,195,285
+143% +$8.1M
SNDX icon
552
Syndax Pharmaceuticals
SNDX
$1.7B
$13.4M 0.02%
1,432,440
+800,800
+127% +$8.81M
DAN icon
553
Dana Inc
DAN
$2.97B
$13.3M 0.02%
777,000
-556,000
-42% -$8.3M
DHI icon
554
D.R. Horton
DHI
$41B
$13.3M 0.02%
103,175
-78,700
-43% -$9.69M
KYMR icon
555
Kymera Therapeutics
KYMR
$8.25B
$13.3M 0.02%
+304,200
New +$10.5M
TER icon
556
Teradyne
TER
$57.2B
$13.2M 0.02%
146,924
-1,700
-1% -$136K
COO icon
557
Cooper Companies
COO
$14.5B
$13M 0.02%
183,160
+1,000
+0.5% +$76.6K
ACAD icon
558
Acadia Pharmaceuticals
ACAD
$4.39B
$13M 0.02%
+603,800
New +$11.2M
BBIO icon
559
BridgeBio Pharma
BBIO
$15.7B
$13M 0.02%
301,361
-215,194
-42% -$7.83M
DLTR icon
560
Dollar Tree
DLTR
$24.9B
$13M 0.02%
130,938
-53,500
-29% -$4.62M
ACI icon
561
Albertsons Companies
ACI
$5.58B
$12.9M 0.02%
601,637
-300,000
-33% -$6.53M
TKR icon
562
Timken Company
TKR
$9.85B
$12.9M 0.02%
+177,828
New +$12.1M
TUSK icon
563
Mammoth Energy Services
TUSK
$130M
$12.8M 0.02%
4,575,000
+425,000
+10% +$1.09M
BR icon
564
Broadridge
BR
$18.2B
$12.8M 0.02%
52,600
-69,300
-57% -$16.5M
FMC icon
565
FMC
FMC
$1.3B
$12.5M 0.02%
+300,000
New +$11.9M
UDR icon
566
UDR
UDR
$12.4B
$12.5M 0.02%
306,100
+193,074
+171% +$8M
ACHC icon
567
Acadia Healthcare
ACHC
$2.85B
$12.4M 0.02%
545,580
+117,000
+27% +$2.77M
MIRM icon
568
Mirum Pharmaceuticals
MIRM
$6.38B
$12.4M 0.02%
243,000
-102,000
-30% -$4.54M
CCK icon
569
Crown Holdings
CCK
$13B
$12.4M 0.02%
+120,000
New +$11.4M
SMA
570
SmartStop Self Storage REIT
SMA
$1.86B
$12.3M 0.02%
+340,000
New +$12M
BRKR icon
571
Bruker
BRKR
$9.79B
$12.3M 0.02%
+298,366
New +$11.5M
SIRI icon
572
SiriusXM
SIRI
$10.2B
$12.2M 0.02%
531,402
ON icon
573
ON Semiconductor
ON
$31.3B
$12.2M 0.02%
232,700
-66,900
-22% -$2.91M
POR icon
574
Portland General Electric
POR
$5.9B
$12.2M 0.02%
+300,000
New +$12.6M
VIK icon
575
Viking Holdings
VIK
$47.5B
$12.2M 0.02%
+228,000
New +$10.1M

Similar funds

Adage Capital Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Adage Capital Partners held 972 positions worth $59.3B, up 9.9% from $54B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Adage Capital Partners's Q2 2025 filing shows 135 new, 326 increased, 323 reduced and 129 closed positions. Its largest new stake was Capital One: 565,828 shares worth $120M. The largest sale was Discover Financial Services, an estimated $163M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q2 2025 buy was Capital One: 565,828 shares worth $120M.
  • Adage Capital Partners added most to CSX Corp in Q2 2025, an estimated $111M increase.
  • Adage Capital Partners's biggest Q2 2025 reduction was 3M, cutting an estimated $159M.
  • Adage Capital Partners fully exited Discover Financial Services in Q2 2025, selling an estimated $163M.
  • Adage Capital Partners's ten largest holdings make up 31% of its $59.3B portfolio in Q2 2025.
  • Adage Capital Partners opened 135 new positions and closed 129 in Q2 2025.
  • Adage Capital Partners's portfolio value rose 9.9% quarter-over-quarter to $59.3B.

Based on Adage Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.